Relational Investors Boost Stake In Manitowoc Company, Inc. (MTW); Push For Food Division Spin Off

Ralph V. Whitworth, who runs Relational Investors, is bullish on Manitowoc Company, Inc. (NYSE:MTW) and has nearly doubled his fund’s position in the company. According to a recent filing with the Securities and Exchange Commission, Relational Investors has increased its holding of the stock by approximately 4.97 million shares, which were bought at an average price of $20.69 apiece. As a result, the fund now holds 11.5 million shares which represent 8.52% of the total number of shares outstanding.

Ralph V. Whitworth

Following the announcement, Manitowoc Company, Inc. (NYSE:MTW) shares rose as much as 12% to a price of $33.19, as reported by Marketwatch. The company has a market cap of $4.36 billion and engages in the manufacturing and sale of cranes and foodservice equipment worldwide. The stock is traded at a trailing Price to Earnings (P/E) ratio of 35.58, which is significantly higher than the industry average of 17.40, and carries an annual dividend of $0.08, which represents a yield of 0.30%. The forward P/E ratio of 15.77 is an indication of market’s belief that the company can improve its earnings potential. Manitowoc Company, Inc. (NYSE:MTW) posted revenues of $850 million and earnings of $0.15 per share for the first quarter of 2014.

Ralph V. Whitworth is also a fan of Clean Harbors Inc (NYSE:CLH), having opened a position which amasses 5.51 million shares or 9.08% of the company’s common stock. His biggest bet continues to be Hewlett-Packard Company (NYSE:HPQ), with Relational Investors holding approximately 27.8 million shares according to its latest 13F report.

According to a report from CNBC‘s Bertha Coombs, Relational Investors believe Manitowoc Company, Inc. (NYSE:MTW) to be undervalued and that Relational urges the company to spin off its food unit. They believe such a move would mean a higher value for the crane company. Relational Investors have also revealed they have presented this idea to the management of the company back in January 2014, but have not heard back from them and their request for a meeting with the board of directors was rejected.

Watch the full video below:

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!